SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001193125-20-267272
Filing Date
2020-10-09
Accepted
2020-10-09 16:47:28
Documents
5

Document Format Files

Seq Description Document Type Size
1 S-3 d68240ds3.htm S-3 175383
2 EX-5.1 d68240dex51.htm EX-5.1 23869
3 EX-23.1 d68240dex231.htm EX-23.1 1891
4 GRAPHIC g68240avita.jpg GRAPHIC 4747
5 GRAPHIC g68240g26c53.jpg GRAPHIC 4803
  Complete submission text file 0001193125-20-267272.txt   215683
Mailing Address 28159 AVENUE STANFORD SUITE 220 VALENCIA CA 91355
Business Address 28159 AVENUE STANFORD SUITE 220 VALENCIA CA 91355 661-367-9170
Avita Therapeutics, Inc. (Filer) CIK: 0001762303 (see all company filings)

IRS No.: 202578762 | State of Incorp.: DE | Fiscal Year End: 0630
Type: S-3 | Act: 33 | File No.: 333-249419 | Film No.: 201233708
SIC: 3841 Surgical & Medical Instruments & Apparatus